Related references
Note: Only part of the references are listed.Efficacy and safety of adalimumab in difficult-to-treat psoriasis
Caterina Lanna et al.
DERMATOLOGIC THERAPY (2020)
Patient sex does not affect endoscopic outcomes of biologicals in inflammatory bowel disease but is associated with adverse events
Mitchell R. K. L. Lie et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2020)
Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults: A Systematic Review
Marieke E. C. van Winden et al.
JAMA DERMATOLOGY (2020)
Outcome following a short period of adalimumab dose escalation as rescue therapy in psoriatic patients
Federico Bardazzi et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2020)
Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
R. B. Warren et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Factors predicting persistence of biologic drugs in psoriasis: a systematic review and meta-analysis
A. Mourad et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Female patients are less satisfied with biological treatment for psoriasis and experience more side-effects than male patients: results from the prospective BioCAPTURE registry
L. S. van Der Schoot et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study
A. Chiricozzi et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Old and New Biological Therapies for Psoriasis
Kirsten Ronholt et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Adalimumab Efficacy in Patients with Psoriasis Who Received or Did Not Respond to Prior Systemic Therapy: A Pooled Post Hoc Analysis of Results from Three Double-Blind, Placebo-Controlled Clinical Trials
Kim A. Papp et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2016)
Clinical predictors of nonresponse to anti-TNF-α agents in psoriatic patients: A retrospective study
Clara De Simone et al.
DERMATOLOGIC THERAPY (2016)
The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries
Pil Hojgaard et al.
RHEUMATOLOGY (2016)
A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis
U. Mrowietz et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Observational Studies
Ehrin J. Armstrong et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study
Bruce E. Strober et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Mechanisms of Disease: Psoriasis.
Frank O. Nestle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
